InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Bisaro Paul, Director. Director active across 3 companies, notably Zoetis Inc.. Cumulatively, 9 reports have been logged. Total volume traded: €374k. The latest transaction was filed on 14 May 2026 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
€23,6997,500 shares@ €3.15980.0070% mcap50.0% of flow
Common Stock
SEC:0001237253-26-000002:0·
Ideal exit: 8 Feb 2027 (T+270)
€23,6997,500 shares@ €3.15980.0070% mcap100.0% of flow
Common Stock
SEC:0001237253-26-000002·
Ideal exit: 8 Feb 2027 (T+270)
US$129,5232,000 shares@ US$64.76160.0004% mcap100.0% of flow
Common Stock
SEC:0001628280-26-034642·
Ideal exit: 7 Feb 2027 (T+270)
€129,5232,000 shares@ €64.76160.0004% mcap50.0% of flow
Common Stock
SEC:0001628280-26-034642:0·
Ideal exit: 7 Feb 2027 (T+270)
2,673 shares
Common Stock
SEC:0001555280-22-000095:0·
€33,53250,000 shares@ €0.67060.14% mcap100.0% of flow
Common Stock
SEC:0001387131-21-008680·
Ideal exit: 13 May 2022 (T+270)
€33,53250,000 shares@ €0.67060.14% mcap50.0% of flow
Common Stock
SEC:0001387131-21-008680:0·
Ideal exit: 13 May 2022 (T+270)
96,864 shares
Common Stock
SEC:0001387131-21-008439·
96,864 shares
Common Stock
SEC:0001387131-21-008439:0·
9 of 9 declarations
About Bisaro Paul
Paul Bisaro is a Board Member at Zoetis Inc., TherapeuticsMD, Inc., and Myriad Genetics Inc. He brings his expertise to the board and participates in strategic discussions. His role is essential in guiding these companies in a competitive environment.
